西安诺和达生物科技有限公司
+86 13662665103 Mon–Fri, 09:00–18:00 GMT+8 Contact Us sales@nhdbio.com
Lot-document scope confirmed before quotation · Research use only
  • Specification Review
  • Lot Documents on Request
  • Business Support · Xi’an
  • Destination Eligibility Confirmed
西安诺和达生物科技有限公司

Quote list

Review quantities before sending your request.

View full quote listContinue browsing productsThis is an enquiry list, not a checkout. No payment is taken.
 Request an Account

Research & insights

Selank Evidence Review: Small Human Studies and GABA Research

By NHD Technical TeamPublished Updated Oct 13, 2026

Selank has limited human comparative literature and a larger mechanistic narrative around GABA signaling. The human reports are small, mostly Russian-language, and do not establish broad international clinical efficacy.

Evidence at a glance

  • A 2008 report compared 30 Selank participants with 32 receiving medazepam in generalized anxiety disorder or neurasthenia.
  • A 2014 report compared Selank and phenazepam in 60 people with anxiety or somatoform diagnoses.
  • A 2016 rat study measured 84 neurotransmission genes and found 45 altered at 1 hour and 22 at 3 hours; that is mechanistic animal evidence.
Documentary behavioral-neuroscience research workspace
AI-generated editorial illustration illustrating the research workflow. It is not a study figure, patient image, product photograph, assay result or catalog lot.

Study record

The 2008 abstract reports similar anxiolytic effects between groups and changes in serum enkephalin activity. The record available through PubMed does not provide the full randomization, masking, attrition and adverse-event detail expected from a modern confirmatory trial.

2008 human report62 total: Selank n=30; medazepam n=32
2014 human report60 participants; comparative clinical report
2016 modelRat frontal cortex after 300 µg/kg Selank or GABA
Gene panel84 genes; 45 changed at 1 hour and 22 at 3 hours
Evidence boundarySmall regional studies and preclinical mechanism, not confirmatory global evidence

Results in context

The 2014 comparison reported anxiolytic and mild nootropic effects and stated that the effect persisted for one week after the last administration. Again, the English-accessible record is an abstract-level report and should not be expanded beyond the stated population and endpoints.

In rats, Selank and GABA produced correlated short-term gene-expression changes in frontal cortex. A related IMR-32 cell study did not find direct Selank-only changes in the same gene panel, illustrating why a proposed GABA mechanism should remain a hypothesis rather than a settled clinical explanation.

What the evidence cannot establish

Small studies and limited accessible methods make bias and generalizability difficult to judge.

Different comparators and diagnoses should not be pooled into one efficacy percentage.

Gene-expression findings in rats and neuroblastoma cells do not establish symptom benefit in people.

Sources & editorial method

This article discusses the source records listed below, with the study models and limitations stated alongside the findings. AI-assisted drafting and image generation were used. The reference list identifies the records behind this article; it is not an independent peer review or verification of a supplied catalog lot.

5 linked records are listed in the references below. Read the editorial and AI-assistance policy.

How to interpret this article

Source-checked on 2026-09-02. Null results, sample size, model/population limits and regulatory scope are retained. This is not medical advice, a customer case or validation of a catalog lot.

Research-use boundary: Catalog materials discussed on this website are for laboratory research, development and manufacturing use only, not for human or veterinary use. This content is not medical advice and does not provide administration instructions.

Primary records and authoritative sources

  1. Selank versus medazepam in GAD and neurastheniaSmall 62-person Russian-language report; PMID 18454096.
  2. Selank versus phenazepam clinical comparisonSmall 60-person Russian-language report; PMID 25176261.
  3. Selank affects expression of genes involved in GABAergic neurotransmissionExperimental study. 2016. PMID 26924987.
  4. PubChem Selank recordSequence, formula, molecular weight and synonyms; CID 11765600.
  5. Selank Administration Affects the Expression of Some Genes Involved in GABAergic NeurotransmissionSelank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission
Research pathways

Continue with structured records

Move from this editorial analysis to the product identity, filtered evidence and controlled terminology behind it.

Related evidence recordsFilter the literature database by product familyResearch material glossaryDefine analytical, identity and evidence terms

Editorial source check: Site evidence editorial team · 2026-09-02

On this page 7 sections

Keep reading

All articles
Editorial comic illustration: Selank Identity Guide. Conceptual cover, not experimental imagery.

Selank Identity Guide: TKPRPGP Sequence and Tuftsin Relationship

Read article
Tirzepatide at 176 Weeks: Reading the Diabetes Results

Tirzepatide at 176 Weeks: Reading the Diabetes Results

Read article
After Semaglutide Withdrawal: Reading the STEP 1 Follow-up

After Semaglutide Withdrawal: Reading the STEP 1 Follow-up

Read article

Selank and GABA: what did the original experiment find?

In Selank and GABA-related research, one type of experiment measures the expression of neurotransmission-related genes. It helps discuss mechanisms, but it is not a direct measure of "how much human anxiety improves."

First, put GABA back in its place

GABA is a signaling molecule in the nervous system. Related research may measure receptors, transport, or other processes, so "related to GABA" is not a single result, nor does it mean a given material is GABA.

How was the 2016 study arranged?

Volkova et al. used real-time PCR in rat frontal cortex to examine a set of neurotransmission-related genes and compare changes after Selank, GABA, and corresponding treatments. The study observed two time points after administration: 1 hour and 3 hours.

These are molecular readouts in rat tissue. This article retains the time and model information and does not present the original study's treatment conditions as methods for human use.

When a correlation is seen, how should it be understood?

The original study reported that some gene change patterns after the two treatments were correlated. This can support further discussion of certain mechanistic links, but it cannot prove that the two materials act in exactly the same way.

A simple analogy can be used: two actions making some lights turn on at the same time does not mean they use the same set of switches, nor does it mean other lights will change in the same way. This analogy only helps explain correlation.

Gene expression, neural signaling, and clinical outcomes are different levels

PCR records related expression readouts. To show how receptor or cellular function changes, corresponding experiments are still needed; to judge human effects, appropriate human studies are also needed.

Therefore, "changes similar to GABA treatment" cannot be expanded into "the same as a drug's clinical effect" or "a specific safety profile has been confirmed."

Turn the original article into a record that can be checked

Record the model, sampled tissue, two time points, methods, and comparison objects, then write the mechanistic explanation proposed by the authors. Readers can then see what was actually measured and what belongs to discussion. Product links can help confirm research materials, but they do not replace paper evidence.

Reading card for this study
ModelInformation to retain: Rat frontal cortex
TimeInformation to retain: 1 hour and 3 hours
MethodInformation to retain: Real-time PCR-related expression detection
Teaching summary. Check the explanation and original sources; this is not a to-scale molecular model or a product test result.
Reading card for this study
ItemInformation to retain
ModelRat frontal cortex
Time1 hour and 3 hours
MethodReal-time PCR-related expression detection
Level of conclusionMolecular mechanism clue, not a measure of human effects

Eighty-four genes are not eighty-four treatment outcomes

The study used real-time PCR to examine 84 neurotransmission-related genes in rat frontal cortex at 1 h and 3 h. The panel included receptors, transporters and other targets. Its size describes assay coverage, not eighty-four improvements or a reduction in human anxiety. Locate the specific gene and comparator before interpreting a result.

Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission · 2016

Original sources and further reading

Sources checked on 2026-10-13. Findings apply to the models and materials studied. Batch quality requires records for the actual batch.

Related research materials

SelankView material identity, specifications, and packaging; documentation needs can be raised with an inquiry.

Ask about specifications, quantity, and required documentation